v1
Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group.
- NobleID
- NI8P19W15R35S18
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/02B28EB8
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims